Literature DB >> 15164288

The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors.

Andreas Machens1, Hans-Jürgen Holzhausen, Christine Lautenschläger, Henning Dralle.   

Abstract

BACKGROUND: The biological behaviour of the tall-cell variant (TCV) of papillary thyroid carcinoma (PTC) remains to be clarified in a multivariate analysis that controls for all relevant clinicopathological parameters. PATIENTS AND METHODS: A retrospective analysis was carried out of 332 consecutive PTC patients operated on at a university hospital between November 1994 and February 2003.
RESULTS: A total of 16 TCV tumours (4.8%) was identified among the 332 PTC patients. Nodal and (predominantly pulmonary) distant metastases were identified at surgery in, respectively, 50% and 31% of TCV tumours. On univariate analysis, only the association between the TCV and distant metastasis retained statistical significance after adjustment for multiple testing. On multivariate logistic regression analysis, the presence of distant metastasis increased more than fourfold [odds ratio (OR) 4.2] the chance of having the TCV of PTC, with controls for extrathyroidal extension, nodal metastasis, operation status, patient gender, categorized patient age, and categorized primary tumour diameter.
CONCLUSION: The increased risk of distant metastasis associated with the TCV morphology of PTC warrants an extensive post-operative search for distant metastasis to facilitate early diagnosis and treatment of tumour deposits in distant organs.

Entities:  

Mesh:

Year:  2004        PMID: 15164288     DOI: 10.1007/s00423-004-0485-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

1.  The many appearances of papillary carcinoma of the thyroid.

Authors:  W A Hawk; J B Hazard
Journal:  Cleve Clin Q       Date:  1976 WINTER

2.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

3.  Prognostic implications of the tall cell variant of papillary thyroid carcinoma.

Authors:  T L Johnson; R V Lloyd; N W Thompson; W H Beierwaltes; J C Sisson
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

4.  Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma.

Authors:  D Simon; J Koehrle; C Reiners; A R Boerner; C Schmutzler; K Mainz; P E Goretzki; H D Roeher
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

5.  Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma.

Authors:  A Machens; R Hinze; C Lautenschläger; H Dralle
Journal:  Arch Surg       Date:  2001-08

6.  Tall cell variant: an aggressive form of papillary thyroid carcinoma.

Authors:  S Prendiville; K D Burman; M D Ringel; B M Shmookler; Z E Deeb; K Wolfe; N Azumi; L Wartofsky; R B Sessions
Journal:  Otolaryngol Head Neck Surg       Date:  2000-03       Impact factor: 3.497

7.  Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.

Authors:  F Grünwald; C Menzel; H Bender; H Palmedo; R Otte; R Fimmers; J Risse; H J Biersack
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

8.  Prognostic value of the tall cell variety of papillary cancer of the thyroid.

Authors:  A Moreno Egea; J M Rodriguez Gonzalez; J Sola Perez; T Soria Cogollos; P Parrilla Paricio
Journal:  Eur J Surg Oncol       Date:  1993-12       Impact factor: 4.424

9.  Tall cell papillary thyroid cancer: incidence and prognosis.

Authors:  J H Terry; S A St John; F J Karkowski; J R Suarez; N H Yassa; C D Platica; J R Marti
Journal:  Am J Surg       Date:  1994-11       Impact factor: 2.565

10.  Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.

Authors:  R Hinze; H J Holzhausen; O Gimm; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1998-09       Impact factor: 4.064

View more
  12 in total

1.  The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes.

Authors:  C Regalbuto; P Malandrino; F Frasca; G Pellegriti; R Le Moli; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

2.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

3.  Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Ashok R Shaha; R Michael Tuttle; Andrew G Sikora; Ian Ganly
Journal:  Thyroid       Date:  2010-02       Impact factor: 6.568

4.  Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Akira Miyauchi; Takuya Higashiyama; Minoru Kihara; Akihiro Miya
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

5.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

6.  Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Authors:  Xiaoguang Shi; Rengyun Liu; Fulvio Basolo; Riccardo Giannini; Xiaopei Shen; Di Teng; Haixia Guan; Zhongyan Shan; Weiping Teng; Thomas J Musholt; Khawla Al-Kuraya; Laura Fugazzola; Carla Colombo; Electron Kebebew; Barbara Jarzab; Agnieszka Czarniecka; Bela Bendlova; Vlasta Sykorova; Manuel Sobrinho-Simões; Paula Soares; Young Kee Shong; Tae Yong Kim; Sonia Cheng; Sylvia L Asa; David Viola; Rossella Elisei; Linwah Yip; Caterina Mian; Federica Vianello; Yangang Wang; Shihua Zhao; Gisele Oler; Janete M Cerutti; Efisio Puxeddu; Shen Qu; Qing Wei; Huixiong Xu; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hongyu Yu; Giovanni Tallini; Elizabeth H Holt; Vasily Vasko; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

Review 7.  Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Authors:  Tobias Carling; Idris T Ocal; Robert Udelsman
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

8.  Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV.

Authors:  Sheng-Hwu Hsieh; Szu-Tah Chen; Chuen Hsueh; Tzu-Chieh Chao; Jen-Der Lin
Journal:  Int J Endocrinol       Date:  2012-12-06       Impact factor: 3.257

Review 9.  Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.

Authors:  Xiaofei Wang; Wenli Cheng; Chongqing Liu; Jingdong Li
Journal:  Oncotarget       Date:  2016-06-28

10.  Squamous Cell Carcinoma of the Thyroid as a Result of Anaplastic Transformation from BRAF-Positive Papillary Thyroid Cancer.

Authors:  Alina Basnet; Aakriti Pandita; Joseph Fullmer; Abirami Sivapiragasam
Journal:  Case Rep Oncol Med       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.